Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies
While these findings are observational and require confirmation in prospective studies, they highlight the potential of GLP-1 therapies to influence long-term musculoskeletal and inflammatory outcomes in patients with diabetes. For more information: Betul Ibis, MD, can be reached at [email protected].
Dei Cas, M., & Ghidoni, R
Do not let total calories drop below your daily floor (1,200 for women, 1,500 for men)
It helps them stick to a treatment plan
Therefore, it is interesting that 2-AAA was decreased in the group with L-carnitine administration, as it suggested a possible decrease in risk for diabetes